e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Non-exhaled biomarkers in the assessment of airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Higher BODE Index in COPD patients correlated with higher number of comorbidities
Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Ashvendra Singh Chawra
Source:
International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Session:
Non-exhaled biomarkers in the assessment of airways disease
Session type:
Thematic Poster Session
Number:
3985
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Ashvendra Singh Chawra. Higher BODE Index in COPD patients correlated with higher number of comorbidities. Eur Respir J 2015; 46: Suppl. 59, 3985
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
COPD and BMI at primary level
Source: International Congress 2015 – Different data in COPD
Year: 2015
Burden of comorbidities and NT-proBNP concentrations in stable COPD patients
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?
Source: International Congress 2014 – Clinical presentations
Year: 2014
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation
versus
stable COPD outpatients
Source: International Congress 2014 – Comorbidities
Year: 2014
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
COPD staging systems and BODE index
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Fatigue in COPD: association with functional status and hospitalisations
Source: Eur Respir J 2013; 41: 565-570
Year: 2013
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Poor agreement between chart-based and objectively identified comorbidities of COPD
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016
Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Evaluation of nutritional status, disease severity and anxiety/depression in COPD patients with different exercise capacity
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept